News & Press

In Memory of Jenna Bockmiller

November 9, 2010

Over the weekend the melanoma community lost a true fighter.  Jenna Bockmiller of California died at the age of 20, after a 6-year battle with melanoma.Her tenacious fight against this disease inspired many in the patient community and each of us …

5 Questions That May Help You Dodge Cancer

November 8, 2010

WASHINGTON— With growing financial and time pressures in medical care, the era of the leisurely doctor’s visit is largely gone.  As visits become increasingly compact, it’s more important than ever for patients to go in prepared …

Promising Phase II Results for New Drug to Treat Advanced Melanoma

November 5, 2010

Roche announced results from a Phase II clinical study of RG7204 (PLX4032), an inhibitor targeting the BRAF protein that is found in half of metastatic melanoma tumors.  The promising data was presented at the seventh International Melanoma Resear …

FDA Extends Deadline for Decision on Ipilimumab

November 3, 2010

The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab.  The FDA was expected to reach a decision by December 25, 2010 but has delayed …

Melanoma Research Gets Boost from Washington, D.C. Patients and Party-goers

November 2, 2010

WASHINGTON, D.C.— For years, treatment options for patients with advanced melanoma have been bleak, with survival averaging around one year after diagnosis.  But as the research community hones in on treatments that may be the first to impro …